Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients

Article Abstract:

The protease inhibitor indinavir causes raises blood sugar levels without a compensatory increase in insulin secretion, according to a study of 12 HIV patients. The drug also caused insulin resistance. This could explain why some HIV patients who take the drug develop hyperglycemia and other metabolic abnormalities.

Author: Buchanan, Thomas A., Dube, Michael P., Edmondson-Melancon, Hannah, Qian, Dajun, Aqeel, Rubina, Johnson, Debra
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
Indinavir, Hyperglycemia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptors levels in HIV lipodystrophy

Article Abstract:

The abnormalities in body fat distribution seen in HIV patients taking protease inhibitors seems to be caused by some type of inflammatory process. These patients also develop insulin resistance, but it appears to be different than the insulin resistance seen in diabetics and obese people.

Author: Mynarcik, Dennis C., McNurlan, Margaret A., Steigbigel, Roy T., Fuhrer, Jack, Gelato, Marie C.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2000
Research, HIV patients, Lipid metabolism disorders, Lipidosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Insulin-like growth factor system in patients with HIV infection: effect of exogenous growth hormone administration

Article Abstract:

Growth hormone increases blood levels of insulin-like growth factor-I (IGF-I) in HIV patients. Growth hormone and IGF-I control body mass, and may therefore be beneficial in patients with AIDS wasting syndrome.

Author: Mynarcik, Dennis C., McNurlan, Margaret A., Steigbigel, Roy T., Fuhrer, Jack, Gelato, Marie C., Frost, Robert A., Lang, Charles H., DeCristofaro, Kim, Garlick, Peter J., Ahnn, Sang
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 1999
Care and treatment, HIV infection, HIV infections, Wasting syndrome, Somatotropin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Causes of, Complications and side effects, Protease inhibitors, Insulin resistance, Physiological aspects
Similar abstracts:
  • Abstracts: Sports participation, age at smoking initiation, and the risk of smoking among US high school students. Trends in Pregnancy-Related Smoking Rates in the United States, 1987-1996
  • Abstracts: Design, implementation, and evaluation at entry of a prospective cohort study of homosexual and bisexual HIV-1-negative men in Belo Horizonte, Brazil: Project Horizonte
  • Abstracts: The effect of training on the provision of elective abortion: a survey of five residency programs. Safety of intra-amniotic digoxin administration before late second-trimester abortion by dilation and evacuation
  • Abstracts: Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Pancreatic and duodenal homeobox gene 1 induces experssion of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia
  • Abstracts: Dental education summits: the challenges ahead. Dental insurance, managed care and traditional practice. Selling your practice at retirement: are there problems ahead?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.